期刊
ISCIENCE
卷 23, 期 9, 页码 -出版社
CELL PRESS
DOI: 10.1016/j.isci.2020.101470
关键词
-
资金
- Swedish Research Council [K2019-01598, 2015-02756]
- Swedish Cancer Society [CAN 2017/544, 18 0491, 2016/445]
- Umea University [ALF-VLL-464591, ALF-VLL-583901]
- Region Vasterbotten (RV
- ALF) [ALF-VLL-464591, ALF-VLL-583901]
- Knut and Alice Wallenberg Foundation [2012.0090]
- Prostatacancerforbundet
- Novo Nordisk Foundation XPS Extension Grant [59307]
- Kempe Foundation
- Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse
- Lion's Cancer Research Foundation
- Umea University
- European Research Council [787472]
- Swedish Cancer Society
- [RV 933125]
- [RV 738911]
Transforming growth factor beta (TGF-beta) enhances migration and invasion of cancer cells, causing life-threatening metastasis. Smad7 expression is induced by TGF-beta to control TGF-beta signaling in a negative feedback manner. Here we report an additional function of Smad7, i.e., to enhance TGF-beta induction of c-Jun and HDAC6 via binding to their regulatory regions, promoting migration and invasion of prostate cancer cells. Lysine 102 in Smad7 is crucial for binding to specific consensus sites in c-Jun and HDAC6, even when endogenous Smad2, 3, and 4 were silenced by siRNA. A correlation between the mRNA expression of Smad7 and HDAC6, Smad7 and c-Jun, and c-Jun and HDAC6 was found in public databases from analyses of prostate cancer tissues. High expression of Smad7, HDAC6, and c-Jun correlated with poor prognosis for patients with prostate cancer. The knowledge that Smad7 can activate transcription of proinvasive genes leading to prostate cancer progression provides clinically relevant information.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据